Literature DB >> 19751980

3- and 6-Substituted 2-amino-4,5,6,7-tetrahydrothieno[2,3-c]pyridines as A1 adenosine receptor allosteric modulators and antagonists.

Luigi Aurelio1, Celine Valant, Heidi Figler, Bernard L Flynn, Joel Linden, Patrick M Sexton, Arthur Christopoulos, Peter J Scammells.   

Abstract

A series of 2-amino-4,5,6,7-tetrahydrothieno[2,3-c]pyridines were prepared and evaluated as potential allosteric modulators at the A(1) adenosine receptor. The structure-activity relationships of the 3- and 6-positions of a series of 2-amino-4,5,6,7-tetrahydrothieno[2,3-c]pyridines were explored. Despite finding that 3- and 6-substituted 2-amino-4,5,6,7-tetrahydrothieno[2,3-c]pyridines possess the ability to recognize an allosteric site on the agonist-occupied A(1)AR at relatively high concentrations, the structural modifications we have performed on this scaffold favor the expression of orthosteric antagonist properties over allosteric properties. This research has identified 2-amino-4,5,6,7-tetrahydrothieno[2,3-c]pyridines as novel class of orthosteric antagonist of the A(1)AR and highlighted the close relationship between structural elements governing allosteric modulation and orthosteric antagonism of agonist function at the A(1)AR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19751980      PMCID: PMC3005586          DOI: 10.1016/j.bmc.2009.08.024

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  12 in total

Review 1.  International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology.

Authors:  Richard R Neubig; Michael Spedding; Terry Kenakin; Arthur Christopoulos
Journal:  Pharmacol Rev       Date:  2003-12       Impact factor: 25.468

2.  Synthesis and biological characterization of [3H] (2-amino-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)-(4-chlorophenyl)-methanone, the first radiolabelled adenosine A1 allosteric enhancer.

Authors:  Pier Giovanni Baraldi; Maria Giovanna Pavani; Edward Leung; Allan R Moorman; Katia Varani; Fabrizio Vincenzi; Pier Andrea Borea; Romeo Romagnoli
Journal:  Bioorg Med Chem Lett       Date:  2006-03-01       Impact factor: 2.823

3.  Structure-activity relationships for enhancement of adenosine A1 receptor binding by 2-amino-3-benzoylthiophenes.

Authors:  R F Bruns; J H Fergus; L L Coughenour; G G Courtland; T A Pugsley; J H Dodd; F J Tinney
Journal:  Mol Pharmacol       Date:  1990-12       Impact factor: 4.436

4.  Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor.

Authors:  P G Baraldi; A N Zaid; I Lampronti; F Fruttarolo; M G Pavani; M A Tabrizi; J C Shryock; E Leung; R Romagnoli
Journal:  Bioorg Med Chem Lett       Date:  2000-09-04       Impact factor: 2.823

5.  Allosteric modulation of the adenosine A(1) receptor. Synthesis and biological evaluation of novel 2-amino-3-benzoylthiophenes as allosteric enhancers of agonist binding.

Authors:  P A van der Klein; A P Kourounakis; A P IJzerman
Journal:  J Med Chem       Date:  1999-09-09       Impact factor: 7.446

6.  2-Aminothiophene-3-carboxylates and carboxamides as adenosine A1 receptor allosteric enhancers.

Authors:  George Nikolakopoulos; Heidi Figler; Joel Linden; Peter J Scammells
Journal:  Bioorg Med Chem       Date:  2005-11-28       Impact factor: 3.641

7.  Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.

Authors:  Pier Giovanni Baraldi; Romeo Romagnoli; Maria Giovanna Pavani; Maria del Carmen Nuñez; Mojgan Aghazadeh Tabrizi; John C Shryock; Edward Leung; Allan R Moorman; Canan Uluoglu; Valeria Iannotta; Stefania Merighi; Pier Andrea Borea
Journal:  J Med Chem       Date:  2003-02-27       Impact factor: 7.446

8.  Synthesis of 2-amino-3-heteroaroylthiophenes and evaluation of their activity as potential allosteric enhancers at the human A1 receptor.

Authors:  Pier Giovanni Baraldi; Maria Giovanna Pavani; John C Shryock; Allan R Moorman; Valeria Iannotta; Pier Andrea Borea; Romeo Romagnoli
Journal:  Eur J Med Chem       Date:  2004-10       Impact factor: 6.514

9.  2-aminothienopyridazines as novel adenosine A1 receptor allosteric modulators and antagonists.

Authors:  Gemma N Ferguson; Celine Valant; James Horne; Heidi Figler; Bernard L Flynn; Joel Linden; David K Chalmers; Patrick M Sexton; Arthur Christopoulos; Peter J Scammells
Journal:  J Med Chem       Date:  2008-09-05       Impact factor: 7.446

10.  Allosteric enhancers of A1 adenosine receptors increase receptor-G protein coupling and counteract Guanine nucleotide effects on agonist binding.

Authors:  Heidi Figler; Ray A Olsson; Joel Linden
Journal:  Mol Pharmacol       Date:  2003-12       Impact factor: 4.436

View more
  7 in total

1.  Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery.

Authors:  Bruce J Melancon; Corey R Hopkins; Michael R Wood; Kyle A Emmitte; Colleen M Niswender; Arthur Christopoulos; P Jeffrey Conn; Craig W Lindsley
Journal:  J Med Chem       Date:  2012-01-06       Impact factor: 7.446

Review 2.  G Protein-coupled Receptor Biased Agonism.

Authors:  Sima Y Hodavance; Clarice Gareri; Rachel D Torok; Howard A Rockman
Journal:  J Cardiovasc Pharmacol       Date:  2016-03       Impact factor: 3.105

3.  Functionally biased modulation of A(3) adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers.

Authors:  Zhan-Guo Gao; Dennis Verzijl; Annelien Zweemer; Kai Ye; Anikó Göblyös; Adriaan P Ijzerman; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2011-06-21       Impact factor: 5.858

Review 4.  Allosteric modulation of purine and pyrimidine receptors.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao; Anikó Göblyös; Adriaan P Ijzerman
Journal:  Adv Pharmacol       Date:  2011

5.  Design, synthesis and evaluation of novel tetrahydropyridothienopyrimidin-ureas as cytotoxic and anti-angiogenic agents.

Authors:  Rasoul Motahari; Mohammad Amin Boshagh; Setareh Moghimi; Fariba Peytam; Zaman Hasanvand; Tayebeh Oghabi Bakhshaiesh; Roham Foroumadi; Hamidreza Bijanzadeh; Loghman Firoozpour; Ali Khalaj; Rezvan Esmaeili; Alireza Foroumadi
Journal:  Sci Rep       Date:  2022-06-11       Impact factor: 4.996

6.  Retrospective ensemble docking of allosteric modulators in an adenosine G-protein-coupled receptor.

Authors:  Apurba Bhattarai; Jinan Wang; Yinglong Miao
Journal:  Biochim Biophys Acta Gen Subj       Date:  2020-04-13       Impact factor: 3.770

7.  Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A1 Receptor.

Authors:  Yinglong Miao; Apurba Bhattarai; Anh T N Nguyen; Arthur Christopoulos; Lauren T May
Journal:  Sci Rep       Date:  2018-11-15       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.